Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.
Ah-Reum Doo, Seung-Nam Kim, Ji-Yeon Park, Ki Ho Cho, Jongki Hong, Kim Eun-Kyung, Sang Kwan Moon, Woo Sang Jung, Hyejung Lee, Jae Han Jung, Hi-Joon Park
Index: J. Ethnopharmacol. 131(2) , 433-42, (2010)
Full Text: HTML
Abstract
A traditional herb, Yi-Gan San, has been widely used for the management of neurodegenerative disorders in traditional East Asian Medicine.The present study investigated the neuroprotective effects of Yi-Gan San in 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cytotoxicity in vitro and in vivo and sought to clarify its underlying mechanisms.The effect of Yi-Gan San on 1-methyl-4-phenylpyridine was measured in terms of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assays, caspase-3 activity, and western blot analysis of phosphorylated Akt, one of the survival-related signaling proteins in SH-SY5Y cells. The effects of Yi-Gan San were also confirmed in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian mouse model using a rotarod test and tyrosine hydroxylase-immunohistochemistry.Pretreatment of Yi-Gan San with 1-methyl-4-phenylpyridine showed a significant protective effect on SH-SY5Y cells and significantly decreased the level of caspase-3 activity compared to the values for the 1-methyl-4-phenylpyridine-treated cells. This process increased the protein expressions of phosphorylated Akt, and an inhibitor of phosphatidylinositol 3-kinase (PI3K)/Akt, LY294002, significantly decreased this protective effect of Yi-Gan San. In the mouse Parkinson's disease model, treatment with Yi-Gan San also significantly improved motor functioning and prevented dopaminergic loss related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine challenge.Using both in vitro and in vivo methods, this study revealed that Yi-Gan San has neuroprotective effects and rescues dopaminergic neurons from 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity, possibly via the PI3K/Akt pathway.Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
2005-10-01
[Bioorg. Med. Chem. Lett. 15(19) , 4221-5, (2005)]
2011-03-24
[J. Ethnopharmacol. 134(2) , 414-21, (2011)]
2009-01-01
[PLoS ONE 4(9) , e7247, (2009)]
1984-04-27
[Science 224(4647) , 405-7, (1984)]
1987-03-20
[Neurosci. Lett. 75(1) , 65-70, (1987)]